Treatment of N9 cells with increasing concentrations of LPS (0·1, 0·5 and 1 μg/ml) showed a significant dose-dependent induction of miR-155 expression, which reached a 25-fold increase in miR-155 levels for the highest LPS concentration tested (Fig. 1a). A similar result was obtained in primary microglia cultures, where it was possible to observe a 12-fold or 21-fold increase in the expression of miR-155 following incubation

with 0·1 or 1 μg/ml LPS, respectively (Fig. 1b). To establish a time–course for this event, changes in miR-155 levels were monitored by qRT-PCR at different time-points (30 min, 1, 2, 4, 18 and 24 hr), following stimulation of N9 cells with Y-27632 ic50 the lowest concentration of LPS (0·1 μg/ml). The levels of miR-155 remained constant until 4 hr after the beginning of the stimulus, when a significant increase was observed with respect to control levels (Fig. 1c). Levels of miR-155 continued to increase, reaching a maximum at 18 hr, but showed a tendency to decrease after

an incubation period of 24 hr. To confirm the results obtained by qRT-PCR, in situ hybridization studies were performed in primary microglia cultures exposed to 0·1 or 1 μg/ml LPS, using an LNA GSK2126458 purchase probe specific for the mature form of miR-155 (Fig. 2). The miR-155 labelling was significantly more intense in the cytoplasm of microglia cells incubated with LPS than in control cells. Since the probe only recognizes the stiripentol mature form of this miRNA, these results further validate the qRT-PCR data presented in Fig. 1(b) and confirm that, under inflammatory conditions, miR-155 expression increases not only in N9 microglia cells but also in microglia primary cells. Primary microglia cells are not easily obtained with high yield, are extremely difficult to transfect and are easily activated by cell culture procedures, also, the responses of N9 cells and primary microglia cultures to LPS treatment are similar, so the subsequent

studies were performed in N9 cells. This cell line, which comprises immortalized mouse-derived microglia cells, has been described as mimicking the behaviour of primary microglia regarding TLR expression, cytokine release and NO production, and has been employed in several studies as an in vitro model to study microglia activation.24–26 The miRNAs exert their regulatory effects mainly at the post-transcriptional level, by targeting complementary or partly complementary mRNAs and inducing mRNA cleavage or translation repression. To identify potential targets of miR-155 that might be relevant in the microglia immune response, we screened the mouse and human miR-155 sequences using the miRBase and PicTar miRNA target identification programmes.